Author:
Butterfield Lisa H,Disis Mary L,Fox Bernard A,Lee Peter P,Khleif Samir N,Thurin Magdalena,Trinchieri Giorgio,Wang Ena,Wigginton Jon,Chaussabel Damien,Coukos George,Dhodapkar Madhav,Håkansson Leif,Janetzki Sylvia,Kleen Thomas O,Kirkwood John M,Maccalli Cristina,Maecker Holden,Maio Michele,Malyguine Anatoli,Masucci Giuseppe,Palucka A Karolina,Potter Douglas M,Ribas Antoni,Rivoltini Licia,Schendel Dolores,Seliger Barbara,Selvan Senthamil,Slingluff Craig L,Stroncek David F,Streicher Howard,Wu Xifeng,Zeskind Benjamin,Zhao Yingdong,Zocca Mai-Britt,Zwierzina Heinz,Marincola Francesco M
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference44 articles.
1. iSBTc: iSBTC/FDA Immunotherapy Biomarker Taskforce. 2008, [
http://www.isbtc.org/news/enews.php
]
2. Atkins MB, Regan M, McDermott D, Mier J, Stanbridge E, Youmans A, Febbo P, Upton M, Lechpammer M, Signoretti S: Carbonic anhydrase IX expression predicts outcome in interleukin-2 therapy of renal cancer. Clin Cancer Res. 2005, 11: 3714-3721. 10.1158/1078-0432.CCR-04-2019.
3. Sabatino M, Kim-Schulze S, Panelli MC, Stroncek DF, Wang E, Tabak B, Kim DW, De Raffaele G, Pos Z, Marincola FM, Kaufman H: Serum vascular endothelial growth factor (VEGF) and fibronectin predict clinical response to high-dose interleukin-2 (IL-2) therapy. J Clin Oncol. 2008,
4. Wolchok JD, Chapman PB: How can we tell when cancer vaccines vaccinate?. J Clin Oncol. 2003, 21: 586-587. 10.1200/JCO.2003.12.065.
5. Panelli MC, Stashower M, Slade HB, Smith K, Norwood C, Abati A, Fetsch P, Filie A, Walters SA, Astry C, Aricó E, Zhao Y, Selleri S, Wang E, Marincola FM: Sequential gene profiling of basal cell carcinomas treated with Imiquimod in a placebo-controlled study defines the requirements for tissue rejection. Genome Biol. 2006, 8: R8-10.1186/gb-2007-8-1-r8.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献